Back

A Czech national administrative real-world study of diagnostics and treatment pathways of non-small-cell lung cancer stratified by disease stage: From data to actionable indicators

2026-02-25 oncology Title + abstract only
View on medRxiv
Show abstract

IntroductionBuilding on our previously published methodology for claims-based pathway mapping, we extended the analysis by incorporating disease staging. The aim of this study was to develop and evaluate quality indicators (QIs) in patients with non-small cell lung cancer (NSCLC). MethodsThis retrospective, longitudinal cohort study spanned 2017-2023, with follow-up data extending to September 2025. Data were obtained from the National Cancer Registry (NCR), the National Registry of Reimbursed ...

Predicted journal destinations